Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.88 USD | +4.29% | +14.39% | -43.26% |
May. 15 | Cabaletta Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Mar. 22 | HC Wainwright Adjusts Cabaletta Bio's Price Target to $30 From $25, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-43.26% | 622M | |
+9.58% | 115B | |
+12.41% | 107B | |
-2.59% | 21.6B | |
-12.38% | 22.31B | |
-5.29% | 19.19B | |
-3.35% | 18.23B | |
-38.57% | 17.62B | |
+7.51% | 14.26B | |
+35.67% | 12.37B |
- Stock Market
- Equities
- CABA Stock
- News Cabaletta Bio, Inc.
- Wells Fargo Raises Price Target on Cabaletta Bio to $39 From $14, Keeps Overweight Rating